Numerous mechanisms have been proposed to explain PCa resistance to ADT and ARPIs, most of which are centered on alterations of AR itself including AR genomic amplifications and expression of constitutively active AR splice variants that lack the C-terminal ligand-binding domain [5]. This evidence concerns the gene AR and posterior cortical atrophy.